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Introduction
This report summarizes work done under NASA Contract NAS9-15566
(5/1/78-8/1/84). The PI conferred with Dr. Dennis Morrison in Tucson, Arizona
on Oct. 19, 1984 concerning a redraft of this final report. At that time it
was deemed appropriate to include only material not covered since submission
of my last progress report (i.e. Jun g , 1983).
Objectives
June 1983 - August 1984.
1) To determine if growth hormone (GH) cells contained within the rat
pituitary gland can be separated from the other hormone producing cell types
by continuous flow electrophoresis (CFE).
2) To determine what role, if any, gravity plays in the electrophoretic
separation of GH cells.
3) To compare in vitro GH release from rat pituitary cells previously
exposed to microgravity conditions vs release from cells not exposed to
microgravity.
4) To determine if the frequency of different hormone producing
pituitary cell types contained in cell suspensions can be quantitated by flow
cytometry.
5) To determine if GH contained within the human post mortem pituitary
gland can be purified by CFE.
Results and Discussion
Objective lit.
Preliminary evidence for electrophoretic separation of CH cells was
accumulated over the past 3 years and was recently published in J. Biophys.
Biochem. Methods (Plank et al., 1983; see enclosed reprint). Positive results
were achieved using a) density gradient electrophoresis and b) CFE on the
McDonnell Douglas (MDAC) device. Results obtained using the latter device are
particularity relevant since this is the experimental unit flown on STS-8. A
summary of this initial study revealed:
a) that GH cells were consistently recovered in the high mobility
fractions (Fig. 1);
b) that GH cells, after CFE, were able to produce and release hormone
in culture up to 14 days (Fig. 2);
c) that GH cells did not apparently have unique electrophoretic
mobilities as determined by microscopic electrophoresis (Fig. 3)
leading to the suggestion that
d) separations achieved on the MDAC device might be attributed to the
high density of the GH cell type (1.07-1.08 g/cm 3 ), thus resulting in
"fall back" in the device during electrophoresis (Fig. 4).
I
NO2dN0OZf
2
NJJW
u
4
d
1	 1
Fig. la. IilecNnphorclie profiles of calls and their GII content in three experiments using the NieDonoell•
Douglas CFES. In RUN I and RUN 2 cells were stored overnight in 0.1 % IISA in Medium 199 prior 1u
separation; in RUN 3, freshly prepared cells were used, Inlet was at fraction 59 in all cases. Cell
migration was [ruin left to right.
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Fig. lb. Electrophorelic profiles of freshly prepared rat pituitary cells and their GII content in tw,
experiments using the McDonnell-Douglas C'F•iS. The effects of changing 1i9' are seen by cumparm,
RUN 7 with RUN 4.
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Fig. • •2. production of Gil by cells ohtuined from single clncimphorctic fractions after separation using
the McDonnell-Douglas CFES. Upper panel shows the anal amount of Gil that uus found in evils and
that accumulated in supernatants of the correspondin g
 cultures of cacti fraction for RUN J. Figs. Ill and
11. Left panel is the rate of Off production per 500f6 cells averaged over 0-2. 2-7. and 7-14 days in
culture after elecirophoretie separation. Right panel is the total GH production in 14 days per 511U(N) cells
in each fraction.
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Fig. 3: 9PAf distributions of suspended rut pituitary cells as determined by microscopic electrophoresis in
D-2 buffer (' D-I(-DMSD)') at low (0.015 g-ions/litre) ionic strength. Upper two panels are distrihulions
obtained by examining two different cell pools on different days: ruproduclbilitY is shown. Lower Iwo
panels are distributions obtained by examining a somatotroph-depleted and a sommotroph-enriched cell
population. N e total number of cells observed.
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Fig. 4. Migration plots of distance migrated as a function of lime in the density gradient column
calculated for cells of varying radius and densit y but all with the same electrophorctic mobilit y. Values
were chosen to he characteristic of known rat pituitary cell subpopulations. and a linear dependence of
[AW on Ficoll concentration was assumed.
4
r1
r^
4.Y
t
I
f
The results from this initial study were important for the following
reasons:
first; prior to publication of these results were no reports in the
literature indicating that electrophoretic separation of different rat
pituitary cell types had ever been attempted or achieved;
second; our experimental evidence (Fig. 1, 2) was consistent with the
hypothesis that GH cells had a unique surface charge density and
third; the possibility of density—driven separations of Gli cells during
CFE appeared to provide an excellent rationale for a CFE epxeriment in
microgravity.
Objective A2.
As explained above, a CFE experiment in microgravity was done to find out
if cell density played a role in our ground based CFE experiments. To our way
of thinking there were 2 possible outcomes of such an experiment:
Outcome #1. Result: similar to ground based data.
Interpretation: cell density does not play a role in
separations on CFE and Gli cells do indeed have unique'
surface charge densities.
Outcome U2. Result; no separation of CH cells, i.e. different result
from ground based experiments.
Interpretation: GH cell density does play a role in CFE
separations; therefore CH cells do not have unique surface
charge densities.
The reader will appreciate that the logistics of conducting a
microgravity CFE experiment are unique and somewhat difficult. To control for
pre and post—processing holding times we carried out additional ground based
studies before and after the flight of STS-8. Holding conditions, as well as
parameters tested in these experiments, are given in Table 1. The actual
experimental protocol for the microgravity experiment is outlined in Table 2
and "event" times are outlined in Table 3.
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Table I
RAT PITUITARY CELL SEPARATION 04 CFESi PROTOCOLS
Hours/Day s	 Parameter+++
Exp Gravity	 ET BE' AE++ ICH Intracell Cult HPLC SOS-PAGE
Condition Hormone
GS-1 1	 150 40 hr 6 day s 0 + + 0 0
GS-2 1	 210 0,5 hr 0,5 hr + + 0 0 0
GS-3 1	 150 72 hr 5 days + + + + +
STS-8 Micro	 300 72 hr 5 days + + 0 + +
GS-4 1	 150 0,5 hr 0.5 hr 0 + + + +
+App roximate time between rat kill and electrophoresls,
++ A
pp roximate time between electrophoresis and cell Processin7•
+++ ICH . Immunocy te chemistr y; Intracellular hormone - RIA/EIA on 0.01 N IlaHCO3
extracts; culture - aMEM + 5% calf serum + antibiotics; IIPLC = reverse phase on
C-18 column.
Table 2
STS-8 PROTOCOL
KILL RATSI
PITUITARY CELL SUSPENSIONI
OG	 IG
1) CFES + IOw HS	 1) CFES + lox HS
2) 199 + 5% CS
	
220C	
2) 199 + 504 CS	
22'C
3) CFES + 10% HS
4) 199 + 5 0M CS	
4•C
1) INTRACELLULAR HORMONE
CONTENT (P,IA)
2) I1119UNOCYTOCHEMISTRY
3) CULTURE
4) HPLC
5) ANALYTICAL GEL
ELECTROPHORESIS
TROPHORESIS	 ELECTROPHORESIS
(TRAY 651	 (TRAY 16) I
SAMPLE TRAYS
POOL FRACTIONS
I
1) INTRACELLULAR HORMONE
CONTENT (RIA)
2) IMMUNOCYTOCHEMISTRY
	 e
3) CULTURE
i
4) HPLC
5) ANALYTICAL GEL
ELECTROPHORESIS
Table 3
STS-8 PITUITARY CELL ELECTROPHORESIS EXPERIMENT
TIME FROM KILL
TASK DATE
HOURS	 DAYS
l) KILL RATS 8/29 -	 -
2) PREPARE CELL SUSPENSION 8/29 4	 -
3) CELLS TO CAPE 8/29 8	 -
4) CELLS INTO CFES SYRINGES 8/29 10	 -
5) ELECTROPHORESIS STS-8 9/1 -	 3
6) LANDING 9/5 -	 8
7) BEGIN SAMPLING TRAY #5 9/5 -	 8
8) END SAMPLING TRAY #5 9/6 -	 9
9) PROCESS CONTROLS TRAY #5 9/6 -	 9
10) BEGIN SAMPLING TRAY N6 9/7 -	 10
11) END SAMPLING TRAY #5 9/7 -	 10
12) PROCESS CONTROLS TRAY N6 9/8 -	 II
t
I
EXP 2
CELLS (x105)
11 z 1+141 5
EXP	
PRL
EXP 2
X
	
(S)I 
%
EXP 2
 GH CELLSH)^ EX
P
8 NOS -CELLS
Results of 4 CFE exps., viz. GS-2, STS-A, GS-3, and GS-4 ouc experimental
designation) are presented graphically in Fig. 5 as expn. 1, 2, 3 one 4
respectively. Clearly, GI1cell separation occurred in mlcrogravity (exp. 2),
thereby confirming that Gil
	 do indeed possess unique surface charge.
(Note: the reason these experimental results are "crowded" into one figure is
simply that they are being submitted for publication in Science in this format
where space is at a premium).
Fig. 5.
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Fig. 5 Results of 4 rat pituitary cell CFE experiments done under unit gravity
(experiments 1,3,4) or microgravity (experiment 7,) conditions. Numbers of anterior
pituitary donors (250 g
	
Sprague Dawley derived rats, hilltop Labs., Scottdale,
PA) used in experiments 1-4 were 50, 134, 50, and 73 respectively. Tissues were
{	 dissociated into single cells with a trypsin-albumin solution (2) and washed 2x (500
xg, IO min, room temperature) in CFE buffer. At this stage cell viability averaged
90 + 5%. In experiments I and 4 cells were injected into the CFE device immediately
after the CFE buffer wash; in experiments 2 and 3 the cells were held at 4°C for 3
days in 5 ml syringes prior to injection. ET values (see pg. ) were 210, 150, 150
and 150 volt-min-cm-1 for exps. 1-4 respectively. Fifty-80 ten ml fractions were
collected into tubes containing 3 ml Alpha modified Eagle's medium and calf serum
(Gibco) such that the final concentration was !x Alpha modified Eagle's medium + 5%
calf corum + penicillin-streptomycin 100 U/ml + gentamycin sulfate 10 pg/ml
(experiments 2 and 3 only). Cells in experiments l and 4 were washed in MEN
containing 0.1% BSA immediately after collection; those in experiments 2 and 3 were
held at 4°C for 5 days prior to washing and counting. Individual fractions were
pooled according to the scheme shown in the first panel of each of the 4
experiments. The average number of cells in cacti pooled fraction (t SEM) was 1.51 t
0.09 x 106 (Exp 1); 2.22 t 0.12 x 10 6 (Exp 2); 2.52 t 0.14 x 10 6 (Exp 3) and 1.72 t
0.10 x 106 (Exp 4). Cells contained in each of these pooled fractions and in the
CFE-washed, non-electrophoresed fraction were analyzed a) by immunocytochemistry to
determine the percereage of different cell types (experiments 1, 2, 3); b) by
specific, homologous radioiifamunoassays to determine intracellular hormone levels
(experiments 1, 2 and 4) ana hormone levels after cell culture (experiments 3, 4)
and c) by HPLC for characterization of intracellular G11 (experiments 2 and 4).
Procedures for immunocytochemistry and antiserum controls are described in (8).
Antisera final dilutions:anti-CH, 1:50,000; anti-PRL, 1:50,000; anti-L1i, 1:10,000.
Differential cell counts were obtained on 500-1000 cells on coded slides by 2 or 3
investigators. The average % of CH, PRL and 1.11 cells contained in the CFE washed,
nonelectrophoresed cells was 35 + 6%, 20 + 5%, and 10 + 3% respectively for
experiments 1, 2 and 3. Intracellular hormone levels were measured on 0.1 M NaHCO3
extracts using RIA kits kindly provided by the National Institute of Arthritis,
Digestive Diseases, and Kidney NIADDK (FS11, 1,11, TS11) or previously validated RIA's
[Gil, PRL-(9)). Results are expressed in terms of standards designated as follows;
CH VII-38C; PRL 10-10B; L11 RP-1; FSH RP-1; and TSH RP-l. Electrophoretic cell
profiles for each of the experiments are numbered according to where cells first
appeared among harvested fractons and are not defined according to actual
electrophoresis channels. Cell viabilities after electrophoresis were 80%, 53%,
56%, 74% in experiments 1-4 respectively. Numbers of cells electrophoresed were 4.9
t	 x 107 , 5.38 x 107 , 3.47 x 107 and 5.15 x 10 7 in experiments 1-4, respectively. Cell
recoveries were 21%, 20%, 73%, and 48% in experiments 1-4. Low recoveries are
attributed to cell clumping in the holding syringe used for injection into the CFE
r
	
	
device. The total number of any given hormone-containing cell type contained in a
pooled fraction is obtained by multiplying the % of immunopositive cells in that
fraction (panels C, E, H, J, L, M) by the total number of cells in that pooled
fraction (see above). Thus, 63% of the total recovered CH cells in Exp 1 were found
in pooled fractions 5, 6 and 7; 67% of the total recovered PRL cells in Exp 1 were
found in pooled fractions 1, 2 and 3. On the basis of both immunocytochemistry and
immunoassay data, there was no indication of preferential cell loss during
electrophoresis.
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Counts on immt►norhemically st. ► 1ied cells contained within tho various
fractions ,otter CFI: wore critical to document cell enrichment. Examples of
the cell appearance in these different experiment 	 ire offered in Fit!. 6.
',ince cello, are necessarily sub)ucted to harsh conditions (e.g. low ionic
strength ht► ffors, lop	 storage at 4°C, etc.), it is Important to document that
we still h, ► vv Intact cells after these experimental inanipulatio ► ir:.	 The images
in Fi ►!. 6 cle,erly show th. ► t this is the case.
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Fig. 6 Morphology of pituitary cells before and after separation on CFF, Cells
were deposited on polylysine-coated cover slips and stained for intracellular
hormone (N). Preabsorption of antisera with excess hormone abolished staining.
Cells were aLio unstained when nonimnn ► ne sera were used at comparable dilutions.
Panels 5-8, x 100; all others x 620. Panels 1-8 show selected cell fractions
obtained from CFE experiment 1; panels 9-12 from CFE experiment >12 (see Fig. 2).
In all cases darkly stained cells are hormone specific while non4tained cells are
grey.	 Panel 1, GIf cells in initial, non-electrophoresed preparation; panel 2,
non-GH cells in electrophoresis fraction 4; panel 3, Gil cells in fraction 6;
panels 4 and 5, 1,11 cells in initial non-electrophoresed preparation at high (6200
and low nu► gnification (1()Ux); panel 6, IM calls in 1r. 7; panel 7, PRI, dells in
Initial non •
-electrophoresed preparation; panel 8, PKL cells in fr. 2; panel 9, C,H
cells in non-electrophoresed preparation before CH buffer wash; panel 10, Gil
cells in neon-electrophoresed preparation after CFF: huf fer. wash; panels I 1 and 12,
Gil cells in frs. 4 and 5, respectively.
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We were especially interested to find out if calls recovered from the CFM:
device were able to produce and release hormone in culture over prolonged
periods. If they did, cell viability during and after CFE would be
demonstrated. Results of such attempts (Fig. 7) show
a) that Gil cells continue to release hormone for at least 12 days in
vitro and
b) that GH cells are separated from PRL cells (which also continue vo
release hormone).
Fig. 7
Fig. 7 In vitro release of immunoreactive PRL and GH from pituitary cells after
separation by CFE. In experiment 3, 5 x 10 4 cells from each of the 10 CFE
fractions (Fig. 2, panel K) were cultured in 200 ul alpha MEM containing 5% calf
serum and antibiotics in 96 well plates (5 wells/fraction) at 37°C under 95% air +
5% CO2 . Total culture time was 8 days with 1 medium change at day 4. In
experiment 4, 75 x 10 5 cells from each of the 11 CFE fractions (Fig. 2, panel N)
were ce..iltured in single T-25 flasks containing 5 ml of the same culture medium.
Total time in culture was 12 days with medium changes at day 4 and 8. In addition
to PRL and GH RIA's (see Fig. 2 legend), medium in experiment 4 was tested for the
presence of bioactive GH using the tibial line assay of Greenspan at al. (10).
(See Table 1).
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The re ,'r:er will recognize that Fig. 7 does not contain culture information
from the microgravity experiment. Unfortunately, cells from microgravity were
heavily contaminated from the MDAC -CFE device. Two major problems associated
with the STS-8 experiment were a) the bacterial contamination and b)
loss of cells attributed to settling in the sample syringe, which forced large
"pooling" of cells recovered from the CFE unit.
We have been analyzing intracellulcr forms of the GH molecule contained
within CFE fraction6 by HPLC. This powerful analytic technique permits
analysis of hormone size and shape depending upon the particular IIPLC column
used. Shown in Fig. 8 are the results of the size of intracellular GH
molecules contained in CFE fractions in exps. 2 and 4. Clearly, most of the
hormone appears to be monomeric ( 22K) G11. On the other hand, our preliminary
data obtained using !{PLC -reverse phase columns support the hypothesis that
different Gil cells contained within different CFE fractions contain hormone
with different shapes ( Fig. 9). These results are very exciting and
completely novel. However, more work will be required for their verification.
!
Fig. 8. Profiles of intracellular Gil extracted from CFE fractions
(experiments 2 and 4, see Fig. 1) after IIPLC on 2x Waters Progein Pak 300 SW
sizing columns. Gil contained in each of the 36 HPLC fractions was measured by
specific GH RIA. Molecules in the sire range of monomeric GH (Mr=22K) elute
in fractions 22-24. The total amount of GH measured in each HPLC run is given
in par .rlltheses. Start and Start-CFES refers to dissociated, but not
electrophoresed cells—before and after CFES ( continuous flow electrophoresis
system buffer wash). Low hormone recoveries in experiment 2 are attributed to
release of GH from cells held at 4°C for 5 days in after CFE.
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Finally, in collaboration with Dr. Richard Grindeland of NASA-Ames, we
have begun to investigate the issue of the biological/immunological activity
ratios of Gil secreted from cells after CFE. The recent, unpublished results
of B/I activities of Gil in media from exp. 4 (Table 4) clearly document
important fundamental differences in these parameters and invite further
study.
Table 4
Bioactive Rat Gil released into culture media
from CFE separated cells in experiment 4.
Combined	 jig Released	 Bioactive GH/Combined	 Fraction/750,000 Cells
Electrophoresis 7.
Fraction +	Change 1++	 Change 2	 Change 3	 Sum
1+2
	 0 3.7	 3.1	 6.8 J
3+4	 0 3.1	 4.0	 7.1
5+6	 0 8.6	 9.9	 18.5
7+8+9	 23.2 29.8	 18.1	 71.1
10+11
	 27.0 40.7	 20.3	 88.0
Start-Buffer +++	24.9 27.5	 J2.9	 65.3
Start-Media	 20.7 51.6	 11.8	 84.1
k
+	 See Fig.	 1 (panels N, 0) for electrophoresis cell profile and intracellular
Gil levels obtained in experiment 4. See Fig. 3 for levels of
immunoassayable 
Gil
	 into the culture medium from the 11 individual
fractions in experiment 4.
++ 750,000 cells in each electrophoresis cell fraction were individually
cultured for a total of	 12 days with 2 intervening changes at day 4 and 8.
After 
Gil
	 of individual fractions (Fig.	 3), medium samples were pooled as
indicated and assayed by tibial line bioassay (7) using 2 x 2 design (4
hypophysectomized 
_V	 rats/point).	 Bovine GH,	 1.5	 IU/mg,	 covering the
dose range of 5-45 pg,
	
used as standard (n-5 animals/point).
	
The values
obtained against bovine Gil were converted
	
to values for rat Gil (3
Iu/mg).
+++ Aliquots of the initial cell suspension which were not electrophoresed but
kept at 4°C in either CFE buffer or medium 199 containing 0.1% bovine serum
albumin for a time period comparable to the length of	 the CFE run.
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5) bioactive Gil perferen-	 5) not done
tially released from high
mobility fractions
6) 6) not done
a. LH and FSH output from
more mobile cells
b. TSH-no evidence for
separation
c. PRL-output from less
mobile cells
It should be obvious to the reader that a great deal of work ties been done to
meet Objective @2. In our view the microgravity CFE experiment was -80% successful.
In a future microgravity experiment we would like to be able to recover large numbers
of uncontaminated cells to find out what effect the microgravity environment may have
on subsequent Gil production/release at both the cellular and molecular level.
A comparison of the experimental results obtained on STS-8 vs ground based
control is given in Table 5.
Table 5
Comparison of data obtained in ground based and microgravity
based CFE pituitary cell separation experiments.
PARAMETER	 UNIT GRAVITY	 MICROGRAVITY
1) Cell profile after 1) spread over -50
electrophoresis	 tubes
2) Cell enrichment-	 2)
immunocytochemistry
a.
Gil
	
2-3x enrichment
in mobile fractions
b. PRL	 b. 3x enrichment in
low mobiity fractions
C. Lll	 c. 2x enrichment in most
mobile area
1) spread over -50 tubes
2)
a. 2x enrichment in
mobile fraction
b. -2x enrichment in
low mobility region
c. 2x enrichment in most
mobile area
3) Cell enrichment-
intracellular
hormone (RIA)
4) Gil cell culture
( RIA)
5) Gil cell culture
(Bioassay)
6) LH, FSH, TSH cell
culture (RIA)
7) Character of GH
after HPLC on gel
sizing columns
8) Character of GH
after HPLC on
on reverse phase
columns
3) parallels immuno-
cytochemistry
4) GH released from
both high and low
mobility somatotrophs
7)
a. Mr
 G11='-)2K for all
regions
b. more Gil from high
mobility regions
8) Evidence for multiple
GH forms in somatotroph
subpopulations
3) parallels immunocyto-
chemistry
4)
Gil
	 released (?)
7)	
r
a. Mr GH=22K for all
regions
b. more Gil from high
mobility regions
8) Evidence for multipleGil
	
in somatotroph
subpopulations
Objective p3.
The "left leg" of our microgravity experimental protocol ( Table 2)
reflects the fact that we were able to store dispersed rat pituitary cells in
a Shuttle Middeck storage locker and subsequently culture them on earth. It
is emphasized that these cells were not subjected to CFE.
The data in Table 6 provide the evidence which suggests that
microgravity-exposed CH cells are unable to release as much hormone as their
corresponding earth-based controls. Thus, GH production ( i.e. GH in medium
intracellular G11) was 20 . 3 times greater from control cells than from those
exposed to microgravity (Table 6). Most interestingly, PRL secretion was
affected in exactly the opposite way. Thus, PRL release was 4x greater from
the same microgravity exposed cells ( Table 6).
Table 6
G11 AND PRL PRODUCTION BY RAT PITUITARY CELLS IN CULTURE AT UNIT GRAVITY
AFTER PREVIOUS EXPOSURE TO MICROGRAVITY OR UNIT GRAVITY CONDITIONS.
Gravity Temp Intracellular GH Total GH released ng CH
Condition ( xg) °C (ng / 1 x 106	cells) from 1 x 106 cells Produced
during 6 day during'6
culture ( ng)+ days++
Micro AMB 540 ± 70 765 225
1 AMB 3,850 t 1,410 16,760 12,910
1 4 11,700 ± 3,240 21,050 9,350
Gravity	 Temp	 Intracellular PRL	 Total PRL released	 ng PRL
Condition ( xg)	 °C	 (ng/ 1 x 10 6 cells)	 from 1 x 10 6 cells	 Produced
during 6 day	 during 6
culture (ng) +
	days++
Micro
	
AMB	 64 ! 5	 5,025	 4,961
1	 AMB	 1,702 ± 395	 3,275	 1,573
1	 4	 2,051 ± 218	 3,600	 1,549
+ 1 x 106 cells in 5 ml aMEM + 5% CS + Antibiotics. Represents total hormone
in medium detected in two media changes.
++Ng hormone produced - hormone released - hormone intracellular at seeding.
a
i
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Is there precedent for microgravity —induced effects at the cellular
level? Yes. The recent data of Cogoli ( 1984; Science) shows that lymphocytes
exposed to ConA in space do not respond in the usual fashion. The
implication(s) of "gravity sensors" within cells is discussed in a manuscript
and talk presented at JPL in Pasadena last December, 1984 (enclosed). A
proposal describing experiments to further confirm and investigate this
microgravity induced "secretory lesion" was submitted to NASA —Life Science in
April, 1984.
Objective p4.
The mammalian anterior pituitary is noted for extreme heterogeneity of
hormone—containing cell types. The investigator interested in separating
these various cell types by physical means is, of course, required to monitor
the quality of those separations by morphological methods. Currently, the
most sensitive and specific of these is immunocychemistry. This technique is
based on the ability of highly specific, non cross —reacting hormone antibodies
to recognize intracellular antigens at high dilutions of antisera ( typically
1:50,000). After incubation with a second antibody system constructed to
provide a staining signal ( e.g. either fluoroscence or enzme—Linked
conjugates) the frequency of specific cell type in a given fraction must be
counted manually under the microscope to obtain quantitative information on
the frequency distributions of that particular cell type.
A typical CFE cell separation experiment will yield 25-50 individual
fractions for staining and subsequent microscopic counting for eahc of the 6
pituitary hormones. Our usual procedure calls for random counting of 500-1000
stained cells on coded slides by 2-3 investigators. As each slide requires a
minimum of 20' to count, the amount of time and effort invested to get the job
done is clearly not trivial.
Approximately 1.5 years ago our Department was given NIH support to buy a
flow cytomete y . Mike Hatfield, a graduate student in my laboratory, has
developed a method to count the different pituitary cell types contained in
pituitary cell suspensions by flow cytometry. Basically the method involves
staining of 200,000 fixed cells in suspension using primary antiserum
followed by incubation in fluoroscein labeled secondary antibody. The laser
rapidly "counts" stained vs unstained cells so that 10,000 cells can be scored
in a very few minutes. A manuscript describing this methodology, together
with data on distributions of GH, PRL and LH containing cells, is currently in
press ( Flow Cytometry —see Appendix). While we have not yet used the method
on cell fractions obtained from the MDAC—CFE device, we are eager to do so in
the future.
Finally, we have begun to explore the possibility that specific hormone
producing cell types have internal structures which can serve as unique
"fingerprints" when the laser interacts with the unstained cell. Our data
indicate that GH cells, by virtue of their extensive complement of
hormone—containing secretory granules, show a high 90° scatter component.
In theory we should be able to sort cells on the basis of this scatter pattern
and evaluate them for B/ I GH production.
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Objective (!5.
Growth hormone cells are noted from their high numbers of cytoplasm!c,
hormone-containing, secretory granules. A major percentage of the tot.'
intracellular hormone is, in fact, associated with these particles. We have
been interested in isolating GH from these particles using the CFE device to
purify the granul2arp for to hormone extraction. Our reasoning has been that
heterogeneity exists within the secretory granule populations, and that some
GH granules contain hormone with higher H/I activity ratios than others.
Further we hypothesize that subpopulations of Gfi-containing granules bear
different surface charge densities on their limiting membranes and, as n
result „ have different electrophoretic mobilities.
Since it is well known that GH granules in the human pituitary resist
autolysis for at least 24 hrs. after death, we have been particularily
interested in applying this approach to the human post mortem pituitary gland.
If we could purify high potency hormone from this source, it could certninly
be used for therapeutic purposes.
That human GH secretory granule bear a surface charge is suggested by the
data in Fig. 10. These show that such particles have a mobility, determined
by gradient density electrophoresis, somewhere between rat and rabbit RBC's.
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The protocol currently in use to prepare a crude human CH secretory
granule fraction is given in Fig. 11. Most experiments use the "left leg" of
this protocol, i.e. electrophoresis of the particle followed by solubilization
for hormone assay. Results from a recent experiment, shown in Fig. 12,
Indicate that immunoreactive Gil continued in the gland of a 11 hr. post-mortem
specimen is associated with particles which had migrated to positions 100-109.
However, results from a similar experiment utilizing material from a 8 hr.
post-mortem gland show that C11 is much more heterogenous in this preparation,
being distributed over fractions 91-140 (Fig. 13). We interpret this result
to indicate that some damage had occurred to the CH in this tissue.
Individual tubes from the experiment depicted in Fig. 12 were pooled
according to the following scheme 0-89 (I) 90-103 (II), 104-109 (III), 110-200
(IV). 8/I activities of Gil in these fractions were I - 0; II - 2.4; III -
2.8; IV - 62.8.
We believe that these results are especially important to the issue of
heterogeneity of Gil in the human pituitary and to processing of pooled samples
of glands. If the distributions in 2 human pituitaries are so different, it
systems probable that hGll preparations currently administered to patients
represent a mixture of electrophoretically distinct hormone species.
Obviously, more work is required to characterize hGH from this source of using
this unique approach.
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Fig. 11
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